Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SHUKRAPHAR and BSE: 524632 (ISIN INE551C01044).
It has a market capitalisation of ₹3,005 crore, a last close of ₹68.62 on 2026-10-19.
Valuation: a price-to-earnings ratio of 136x, a price-to-book ratio of 33.45x, a dividend yield of 0.0%.
Profitability: return on equity of 28.9%, return on capital employed of 36.5%, an operating margin of 50.7%.
Growth: sales growth of -1.2% a year over three years, net profit growth of 71.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.06x.
| Metric | Value |
|---|---|
| Market capitalisation | 3,005 |
| Last close | ₹68.62 |
| P/E (TTM) | 136x |
| P/B | 33.45x |
| Dividend yield | 0.0% |
| ROE (FY) | 28.9% |
| ROCE (FY) | 36.5% |
| Operating margin (TTM) | 50.7% |
| Sales growth, 3-year CAGR | -1.2% |
| Profit growth, 3-year CAGR | 71.0% |
| Debt / equity | 0.06x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means